|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Chronic kidney disease stage 3 | 21-Aug-2023 | active |
| Proteinuria due to type 2 diabetes mellitus | 21-Aug-2023 | active |
| Ischemic heart disease | 05-Jul-2021 | active |
| Fibromyalgia | 05-Feb-2014 | active |
| Chronic kidney disease stage 2 | 03-May-2010 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 03-May-2010 | active |
| Disorder of kidney due to diabetes mellitus | 01-Dec-2003 | active |
| Chronic kidney disease stage 1 | 01-Dec-2003 | active |
| Chronic sinusitis | 26-Apr-2003 | active |
| Anemia | 06-Mar-2000 | active |
| Prediabetes | 23-Feb-1998 | active |
| Metabolic syndrome X | 23-Feb-1998 | active |
| Sepsis | 04-May-1994 | active |
| Essential hypertension | 28-Dec-1987 | active |
Medication list
| No known medications |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 09-Jun-2025 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 05-Jul-2021 |
| SARS-CoV-2 mRNA vaccine | 10-May-2021 |
| Live attenuated Human alphaherpesvirus 3 only vaccine product | 29-Jun-2020 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 23-Jan-2023 | - |
| Assessment of health and social care needs | 23-Jan-2023 | - |
| Screening for drug abuse | 23-Jan-2023 | - |
| Assessment of substance use | 23-Jan-2023 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 23-Jan-2023 | - |
| Medication reconciliation | 24-Oct-2022 | - |
| Assessment of anxiety | 24-Oct-2022 | - |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 24-Oct-2022 | - |
| Oxygen administration by mask | 22-Dec-2020 | Hypoxemia (disorder) |
| Placing subject in prone position | 22-Dec-2020 | Hypoxemia (disorder) |
| Plain X-ray of chest | 13-Dec-2020 | - |
| Screening for domestic abuse | 24-Aug-2020 | - |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Musculoskeletal care | 12-Jan-2014 | Localized primary osteoarthritis of the hand |
|
||
| Diabetes self management plan | 23-Feb-1998 | Prediabetes |
|
||
| Lifestyle education regarding hypertension | 28-Dec-1987 | Essential hypertension (disorder) |
|
||
| Weight management program | 22-Dec-1986 | - |
Vital Signs
| Vital Signs | 2025-06-09 | 2025-04-07 |
|---|---|---|
| Body Height | 162.7 cm | 162.7 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 0 {score} | 0 {score} |
| Body Weight | 84.8 kg | 84.8 kg |
| Body mass index (BMI) [Ratio] | 32 kg/m2 | 32 kg/m2 |
| Diastolic Blood Pressure | 73 mm[Hg] | 70 mm[Hg] |
| Systolic Blood Pressure | 96 mm[Hg] | 99 mm[Hg] |
| Heart rate | 73 /min | 72 /min |
| Respiratory rate | 16 /min | 12 /min |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 09-JUN-2025 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 83.3 | 70 - 139 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 19.8 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.0 H | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 9.3 | 8.4 - 10.3 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 137.8 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 5.1 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 103.4 | 98 - 108 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20.8 L | 22 - 32 | mmol/L |
| Appearance of Urine | Cloudy urine | ||
| Odor of Urine | Urine smell ammoniacal | ||
| Clarity of Urine | Translucent | ||
| Color of Urine | Brown color | ||
| Glucose [Mass/volume] in Urine by Test strip | 2.1 H | 0 - 0.8 | mg/dL |
| Glucose [Presence] in Urine by Test strip | ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 0.2 | 0 - 1 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 13.1 | 0 - 20 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test = ++ | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.005 - 1.03 | {nominal} |
| pH of Urine by Test strip | 5.3 | 4.6 - 7 | pH |
| Protein [Mass/volume] in Urine by Test strip | 296.3 H | 0 - 14 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = ++ | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative | ||
| Hemoglobin A1c/Hemoglobin.total in Blood | 3.1 L | 4 - 6 | % |
| Glucose [Mass/volume] in Blood | 83.3 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 19.8 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 4.0 H | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.3 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Blood | 137.8 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 5.1 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 103.4 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 20.8 L | 22 - 29 | mmol/L |
Device Use
| Device | Date (since) |
|---|---|
| Home nebulizer (physical object) | 26-Apr-2003 |
| Blood glucose meter (physical object) | 23-Feb-1998 |